2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate

被引:0
|
作者
Victor S. Pribluda
Edward R. Gubish
Edward R. Gubish
Theresa M. LaVallee
Anthony Treston
Glenn M. Swartz
Shawn J. Green
机构
[1] EntreMed Inc.,
来源
关键词
2-methoxyestradiol; angiogenesis; endothelial cells; antiangiogenic therapy; cancer steroid;
D O I
暂无
中图分类号
学科分类号
摘要
2-Methoxyestradiol, once considered an inacitve end-metabolite of estradiol, has recently emerged as a very promising agent for cancer treatment. It is orally active in a wide range of tumor models, and inhibits tumor growth at doses showing non clinical signs of toxicity. 2ME2 targets both the tumor cell and endothelial cell compartments by inducing apoptosis in rapidly proliferating cells and inhibiting blood vessel formation at several stages in the angiogenic cascade. Moreover, the ability of 2ME2 to inhibit metastic spread in several models adds to its therapeutic value for cancer treatment at various stages of the disease. Though the mechanism of action is still undefined, several potential molecular targets and pathways of activation have been suggested.
引用
收藏
页码:173 / 179
页数:6
相关论文
共 50 条
  • [1] 2-methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate
    Pribluda, VS
    Gubish, ER
    Gubish, ER
    LaVallee, TM
    Treston, A
    Swartz, GM
    Green, SJ
    [J]. CANCER AND METASTASIS REVIEWS, 2000, 19 (1-2) : 173 - 179
  • [2] Antiproliferative effects of 2-methoxyestradiol on breast cancer cells
    Recinos, DA
    Thomas, T
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1062 - A1062
  • [3] Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice
    Funakoshi, Taisaku
    Birsner, Amy E.
    D'Amato, Robert J.
    [J]. EXPERIMENTAL EYE RESEARCH, 2006, 83 (05) : 1102 - 1107
  • [4] Antiangiogenic, antimigratory and antiinflammatory effects of 2-methoxyestradiol in zebrafish larvae
    Quezada, Marisol
    Alvarez, Marjorie
    Pena, Oscar A.
    Henriquez, Soledad
    d' Alencon, Claudia A.
    Lange, Soledad
    Oliva, Barbara
    Owen, Gareth I.
    Allende, Miguel L.
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2013, 157 (02): : 141 - 149
  • [5] 2-Methoxyestradiol as a Potential Cytostatic Drug in Gliomas?
    Kirches, E.
    Warich-Kirches, M.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (01) : 55 - 65
  • [6] 2-methoxyestradiol, an endogenous estradiol metabolite, differentially inhibits granulosa and endothelial cell mitosis: A potential follicular antiangiogenic regulator
    Shang, WR
    Konidari, I
    Schomberg, DW
    [J]. BIOLOGY OF REPRODUCTION, 2001, 65 (02) : 622 - 627
  • [7] Antimitogenic effects of 2-methoxyestradiol, an endogenous metabolite of estradiol, are blocked by PPAR-gamma antagonist: Is 2-methoxyestradiol and endogenous PPAR-gamma ligand?
    Dubey, RK
    Gillespie, DG
    Wright, M
    Meyer, M
    Jackson, EK
    [J]. HYPERTENSION, 2004, 44 (04) : 517 - 518
  • [8] The endogenous estradiol metabolite 2-methoxyestradiol is a potent aromatase inhibitor
    Seeger, H
    Huober, J
    Deuringer, FU
    Mueck, AO
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 570 - 570
  • [9] Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease
    Parada-Bustamante, Alexis
    Valencia, Cecilia
    Reuquen, Patricia
    Diaz, Patricia
    Rincon-Rodriguez, Ramiro
    Orihuela, Pedro A.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2015, 15 (05) : 427 - 438
  • [10] Antiproliferative activity and toxicity of 2-methoxyestradiol in cervical cancer xenograft mice
    Li, L
    Da, J
    Landström, M
    Ulmsten, U
    Fu, X
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) : 301 - 307